Caloric restriction extends lifespan in virtually every organism studied, from yeast to primates, through activation of AMPK, inhibition of mTOR, and sirtuins — but human evidence remains limited to biomarker improvements rather than direct longevity data.
Caloric restriction (CR) — reducing calorie intake by 20–40% without malnutrition — extends lifespan in yeast, worms, flies, mice, and rhesus monkeys. The primary mechanisms are activation of AMPK (an energy sensor), inhibition of mTOR (a growth-promoting pathway), and activation of sirtuins (NAD+-dependent deacetylases). Human CR trials show improvements in metabolic biomarkers associated with longevity, but direct human longevity data do not yet exist.
A landmark 2009 study by Colman et al. in Science demonstrated that 30% caloric restriction in rhesus monkeys reduced age-related disease incidence by 50% and improved survival, providing the first primate evidence for CR's longevity effects. The CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) trial (Ravussin et al., 2015) — the first controlled CR trial in healthy humans — found that 2 years of 12% caloric restriction (less than the intended 25%) reduced metabolic syndrome risk factors, inflammatory markers, and thyroid hormone levels (a marker of reduced metabolic rate), suggesting a shift toward a longevity-associated metabolic phenotype. Fontana & Partridge (2015) in Cell reviewed the molecular mechanisms, concluding that CR's benefits operate primarily through nutrient-sensing pathways (mTOR, AMPK, sirtuins, IGF-1).
"Caloric restriction in rhesus monkeys reduced age-related disease incidence by 50% and improved survival."
— Colman et al., Science 2009
The NIA has funded extensive research into caloric restriction and its mimetics, noting that while CR extends lifespan in animal models, its translation to humans is uncertain. The NIA does not recommend CR as a longevity strategy for healthy humans, citing the risks of nutritional deficiency, muscle loss, and reduced bone density. The NIA's CALERIE trial was designed specifically to assess the safety and feasibility of moderate CR in healthy adults.
Strict caloric restriction is not recommended for most healthy adults due to the difficulty of sustaining it without nutritional deficiency and the risks of muscle and bone loss. However, the molecular pathways activated by CR can be partially engaged through: time-restricted eating (compressing food intake into an 8–10 hour window); protein restriction (particularly methionine restriction); regular aerobic exercise (which activates AMPK); and pharmacological CR mimetics such as metformin and rapamycin (currently under investigation in clinical trials). Avoiding chronic caloric excess — which chronically suppresses AMPK and activates mTOR — is the most practical application of CR biology.
Vitaei verdict
Caloric restriction has robust longevity evidence in animal models and improves longevity biomarkers in humans, but strict CR is not recommended. Engaging CR pathways through exercise, time-restricted eating, and avoiding caloric excess is more practical.